OINDP CONFERENCE

INHALASIA 2026

COMING SOON

A CONFERENCE DRIVEN BY THE INDUSTRY

WITH FOCUS ON INNOVATION, ADVANCEMENTS, CHALLENGES AND NETWORKING

We are proud to present Inhalasia 2025, the first dedicated national conference focused exclusively on inhalation drug delivery. Designed, driven, and defined by India’s top pharmaceutical companies. This landmark event brings together R&D leaders, formulation scientists, regulatory experts, and device innovators under one roof to explore the next generation of inhalation therapies. From cutting-edge dry powder inhalers (DPIs) to smart nebulizers, metered dose inhalers, soft mist therapies and nasal delivery systems, every session reflects the real-world challenges, needs, and breakthroughs happening across India’s rapidly growing respiratory therapeutics landscape.

SPEAKERS

ATTENDEES

Where is the Event :

TO BE ANNOUNCED

When is the Event :

TO BE ANNOUNCED

LIMITED SPOTS AVAILABLE

APPLY FOR YOUR PLACE

This event is available to attend by invitation only. Please contact us or use the registration form to apply for a place, we will send you a confirmation once your details are accepted.

Some market insights

What they're saying about this conference..

Rajiv Popat

Partner

Inhalasia 2025 is not just another scientific event—it’s an industry-driven initiative. The agenda has been curated directly by leaders from India’s top pharmaceutical companies, ensuring that every topic is practical, relevant, and future-focused. The conference serves as a national platform for: Knowledge exchange on inhalation technologies Collaboration between pharma, device, and regulatory sectors Showcasing India’s capabilities in global respiratory drug development Expect deep technical insights, product innovation showcases, and high-value networking—all within a format designed to foster collaboration and speed up innovation.

Chromcore Lifesciences, Apex Inhalation

Shraddha Dangat

Associate Director - Sales

Inhalasia! Thrilled to be part of the upcoming forum on Scientific, Regulatory & Analytical Science for Inhalation Products . As inhalation therapies continue to grow in significance, especially in the context of respiratory and systemic drug delivery, this event couldn’t be more timely.What excites me most is the opportunity to engage with experts across the pharma ecosystem—regulators, scientists, and industry leaders. Events like these are essential for aligning science with regulation and ensuring quality, safety, and efficacy in inhalation drug development.